Dabur India Unveils Strategic Growth Vision and Reports Strong Q2 FY27 Results
Dabur India Ltd 路 Investor Presentation 路 05 Nov 2026, 9:02 pm
Dabur India Unveils Strategic Growth Vision and Reports Strong Q2 FY27 Results In Q2 FY27, Dabur India delivered consolidated revenue of INR 3,563 Cr (+11.6% YoY), operating profit of INR 632 Cr (+7.5% YoY), and PAT of INR 505 Cr (+11.7% YoY), supported by India FMCG volume growth of 5.5% and 20.0% international revenue growth. Under its IGNITE and Vision VII framework (FY25鈥揊Y28), the company targets double-digit growth in FY27, backed by a 150 bps AdPro increase, premium portfolio expansion targeting 23% by FY28, rationalization of 350+ SKUs, and 1.5x cost-savings acceleration via Project Saksham.
Original exchange filing (PDF)
More announcements from Dabur India Ltd
- Re-affirmation of Credit Rating by CRISIL Ratings Limited 路 17 Nov 2026
- Change in Senior Management Personnel of the Company 路 14 Nov 2026
- Closure of Dabur International Limited, United Kingdom Branch, a branch of the wholly owned subsidiary of the Company. 路 14 Nov 2026
- Submission of information under Regulation 30(5) of the SEBI (LODR) Regulations, 2015 路 13 Nov 2026
- Dissolution of Dabur Pars LLC a subsidiary of Dabur International Limited, a wholly owned subsidiary of the Company. 路 11 Nov 2026
- Closure of Atlanta Body and Health Products (Pty) Ltd., a wholly owned subsidiary of Dermoviva Skin Essentials Inc. a step down subsidiary of the Company. 路 10 Nov 2026
- Transcript of Analyst/ Institutional Investor Meet held on November 05, 2026 路 10 Nov 2026
- Receipt of administrative warning letter from SEBI 路 06 Nov 2026
